<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">29901151</PMID>
      <DateCompleted>
        <Year>2018</Year>
        <Month>10</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>12</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1791-3004</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>18</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2018</Year>
              <Month>Aug</Month>
            </PubDate>
          </JournalIssue>
          <Title>Molecular medicine reports</Title>
          <ISOAbbreviation>Mol Med Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Eph/ephrin signalling serves a bidirectional role in lipopolysaccharide‑induced intestinal injury.</ArticleTitle>
        <Pagination>
          <StartPage>2171</StartPage>
          <EndPage>2181</EndPage>
          <MedlinePgn>2171-2181</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3892/mmr.2018.9169</ELocationID>
        <Abstract>
          <AbstractText>A growing body of evidence has demonstrated that Eph/ephrin signalling may serve a central role in intestinal diseases. However, whether erythropoietin‑producing hepatocellular (Eph)/ephrin signalling is associated with the development of post‑infectious irritable bowel syndrome (PI‑IBS) is still unknown. In the present study, the role of Eph/Ephrin signalling in lipopolysaccharide (LPS)‑induced intestinal injury was evaluated in vivo and in vitro. LPS treatment significantly increased the levels of proinflammatory mediators [monocyte chemoattractant protein‑1, tumour necrosis factor α, interleukin (IL)‑1β, IL‑6, intercellular adhesion molecule 1 and vascular cell adhesion molecule‑1], activated the EphA2‑Ephrin A1, protein kinase B (Akt)‑nuclear factor (NF)‑κB, Src‑NF‑κB and Wnt/β‑catenin signalling pathways, and inhibited EphB1‑Ephrin B3 signalling in colon tissues, and primary cultured enteric neuronal and glial cells. Notably, EphA2 monoclonal antibody (mAb) treatment or Ephrin B3 overexpression could partially alleviate the LPS‑induced upregulation of proinflammatory mediators, and Akt‑NF‑κB, Src‑NF‑κB and Wnt/β‑catenin signalling pathways. In addition, EphA2 mAb treatment could partially inhibit LPS‑induced inactivation of EphB‑Ephrin B3 signalling, while Ephrin B3 overexpression could abrogate LPS‑induced activation of EphA2‑Ephrin A1 signalling. EphB1/Ephrin B3 signalling may antagonise the EphA2/Ephrin A1‑dependent pathway following LPS treatment. The results associated with the EphA2 signaling pathway, indicated that Eph/ephrin signalling may serve a bidirectional role in LPS‑induced intestinal injury. Eph/ephrin signalling may be a novel therapeutic target for LPS‑induced intestinal injury and potentially PI‑IBS.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xiong</LastName>
            <ForeName>Ying</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, Shenzhen Longhua District Central Hospital, Shenzhen, Guangdong 518110, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Kai-Xue</ForeName>
            <Initials>KX</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, The Second People's Hospital of Shenzhen, Shenzhen, Guangdong 518035, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wei</LastName>
            <ForeName>Hong</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, The Second People's Hospital of Shenzhen, Shenzhen, Guangdong 518035, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiao</LastName>
            <ForeName>Lu</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, The Second People's Hospital of Shenzhen, Shenzhen, Guangdong 518035, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Shao-Yong</ForeName>
            <Initials>SY</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, MD 21205‑2195, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zeng</LastName>
            <ForeName>Li</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology, The Second People's Hospital of Shenzhen, Shenzhen, Guangdong 518035, P.R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>06</Month>
          <Day>14</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Mol Med Rep</MedlineTA>
        <NlmUniqueID>101475259</NlmUniqueID>
        <ISSNLinking>1791-2997</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D036382">Ephrin-A1</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D036389">Ephrin-B3</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.10.1</RegistryNumber>
          <NameOfSubstance UI="D036104">Receptor, EphA2</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.10.1</RegistryNumber>
          <NameOfSubstance UI="D036225">Receptor, EphB1</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036382" MajorTopicYN="N">Ephrin-A1</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036389" MajorTopicYN="N">Ephrin-B3</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007413" MajorTopicYN="N">Intestinal Mucosa</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007422" MajorTopicYN="N">Intestines</DescriptorName>
          <QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043183" MajorTopicYN="N">Irritable Bowel Syndrome</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>
          <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036104" MajorTopicYN="N">Receptor, EphA2</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D036225" MajorTopicYN="N">Receptor, EphB1</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2017</Year>
          <Month>12</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>6</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">29901151</ArticleId>
        <ArticleId IdType="pmc">PMC6072232</ArticleId>
        <ArticleId IdType="doi">10.3892/mmr.2018.9169</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Oświęcimska J, Szymlak A, Roczniak W, Girczys-Połedniok K, Kwiecień J. New insights into the pathogenesis and treatment of irritable bowel syndrome. Adv Med Sci. 2017;62:17–30. doi: 10.1016/j.advms.2016.11.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.advms.2016.11.001</ArticleId>
            <ArticleId IdType="pubmed">28135659</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mearin F, Ciriza C, Mínguez M, Rey E, Mascort JJ, Peña E, Cañones P, Júdez J. en nombre de la SEPD; la semFYC, et al: Clinical practice guidelines: Irritable bowel syndrome with constipation and functional constipation in adults: Concept, diagnosis, and healthcare continuity. (Part 1 of 2) Atencion Primaria. 2017;49:42–55. doi: 10.1016/j.aprim.2016.11.003. (In Spanish)</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.aprim.2016.11.003</ArticleId>
            <ArticleId IdType="pmc">PMC6875955</ArticleId>
            <ArticleId IdType="pubmed">28027792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sundin J, Rangel I, Repsilber D, Brummer RJ. cytokine response after stimulation with key commensal bacteria differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) patients compared to healthy controls. PLoS One. 2015;10:e0134836. doi: 10.1371/journal.pone.0134836.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0134836</ArticleId>
            <ArticleId IdType="pmc">PMC4569289</ArticleId>
            <ArticleId IdType="pubmed">26366730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mondelaers SU, Theofanous SA, Florens MV, Perna E, Aguilera-Lizarraga J, Boeckxstaens GE, Wouters MM. Effect of genetic background and postinfectious stress on visceral sensitivity in Citrobacter rodentium-infected mice. Neurogastroenterol Motil. 2016;28:647–658. doi: 10.1111/nmo.12759.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/nmo.12759</ArticleId>
            <ArticleId IdType="pubmed">26728091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lan C, Sun XN, Zhou XC, Yang B, Huang BL, Deng TZ, He ZT, Han XY. Preinduced intestinal HSP70 improves visceral hypersensitivity and abnormal intestinal motility in PI-IBS mouse model. Asian Pac J Trop Med. 2016;9:302–305. doi: 10.1016/j.apjtm.2016.01.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.apjtm.2016.01.022</ArticleId>
            <ArticleId IdType="pubmed">26972407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polster AV, Friberg P, Neve BL, Törnblom H, Simren M. Autonomic nervous system function in patients with Irritable Bowel Syndrome (IBS): Relevance for symptoms? Gastroenterology. 2017;152(Suppl 1):S724. doi: 10.1016/S0016-5085(17)32517-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0016-5085(17)32517-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menzies V, Jallo N, Kinser P, Robins JL, An K, Driscoll C, Starkweather A, Bajaj JS, Lyon DE. Shared symptoms and putative biological mechanisms in chronic liver disease: Implications for biobehavioral research. Biol Res Nurs. 2015;17:222–229. doi: 10.1177/1099800414541541.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1099800414541541</ArticleId>
            <ArticleId IdType="pmc">PMC5818716</ArticleId>
            <ArticleId IdType="pubmed">25037448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hyland NP, Cryan JF. Microbe-host interactions: Influence of the gut microbiota on the enteric nervous system. Dev Biol. 2016;417:182–187. doi: 10.1016/j.ydbio.2016.06.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2016.06.027</ArticleId>
            <ArticleId IdType="pubmed">27343895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rao M, Rastelli D, Dong L, Chiu S, Setlik W, Gershon MD, Corfas G. Enteric glia regulate gastrointestinal motility but are not required for maintenance of the epithelium in mice. Gastroenterology. 2017;153:1068–1081.e7. doi: 10.1053/j.gastro.2017.07.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2017.07.002</ArticleId>
            <ArticleId IdType="pmc">PMC5623141</ArticleId>
            <ArticleId IdType="pubmed">28711628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cashman MD, Martin DK, Dhillon DK, Puli SR. Irritable bowel syndrome: A clinical review. Curr Rheumatol Rev. 2016;12:13–26. doi: 10.2174/1573397112666151231110521.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1573397112666151231110521</ArticleId>
            <ArticleId IdType="pubmed">26717952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li S, Fei G, Fang X, Yang X, Sun X, Qian J, Wood JD, Ke M. Changes in enteric neurons of small intestine in a rat model of irritable bowel syndrome with diarrhea. J Neurogastroenterol Motil. 2016;22:310–320. doi: 10.5056/jnm15082.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5056/jnm15082</ArticleId>
            <ArticleId IdType="pmc">PMC4819870</ArticleId>
            <ArticleId IdType="pubmed">26645247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park I, Lee HS. EphB/ephrinB signaling in cell adhesion and migration. Mol Cells. 2015;38:14–19. doi: 10.14348/molcells.2015.2116.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14348/molcells.2015.2116</ArticleId>
            <ArticleId IdType="pmc">PMC4314128</ArticleId>
            <ArticleId IdType="pubmed">25475547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barquilla A, Pasquale EB. Eph receptors and ephrins: Therapeutic opportunities. Annu Rev Pharmacol Toxicol. 2015;55:465–487. doi: 10.1146/annurev-pharmtox-011112-140226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-pharmtox-011112-140226</ArticleId>
            <ArticleId IdType="pmc">PMC4388660</ArticleId>
            <ArticleId IdType="pubmed">25292427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen X, Cheng ZR, Zhang SJ, Werling D, Wathes DC. Combining genome wide association studies and differential gene expression data analyses identifies candidate genes affecting mastitis caused by two different pathogens in the dairy cow. Open J Anim Sci. 2015;5:358–393. doi: 10.4236/ojas.2015.54040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4236/ojas.2015.54040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang M, Jeong W, Bae H, Lim W, Bazer FW, Song G. Bifunctional role of ephrin A1-Eph system in stimulating cell proliferation and protecting cells from cell death through the attenuation of ER stress and inflammatory responses in bovine mammary epithelial cells. J Cell Physiol. 2018;233:2560–2571. doi: 10.1002/jcp.26131.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.26131</ArticleId>
            <ArticleId IdType="pubmed">28777434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han J, Xu Y, Yang D, Yu N, Bai Z, Bian L. Effect of polysaccharides from acanthopanax senticosus on intestinal mucosal barrier of escherichia coli lipopolysaccharide challenged mice. Asian-Australas J Anim Sci. 2016;29:134–141. doi: 10.5713/ajas.15.0534.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5713/ajas.15.0534</ArticleId>
            <ArticleId IdType="pmc">PMC4698680</ArticleId>
            <ArticleId IdType="pubmed">26732337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dun MD, Chalkley RJ, Faulkner S, Keene S, Avery-Kiejda KA, Scott RJ, Falkenby LG, Cairns MJ, Larsen MR, Bradshaw RA, Hondermarck H. PProteotranscriptomic profiling of 231-BR breast cancer cells: Identification of potential biomarkers and therapeutic targets for brain metastasis. Mol Cell Proteomics. 2015;14:2316–2330. doi: 10.1074/mcp.M114.046110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/mcp.M114.046110</ArticleId>
            <ArticleId IdType="pmc">PMC4563718</ArticleId>
            <ArticleId IdType="pubmed">26041846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong JY, Shin MH, Douglas IS, Chung KS, Kim EY, Jung JY, Kang YA, Kim SK, Chang J, Kim YS, Park MS. Inhibition of EphA2/EphrinA1 signal attenuates lipopolysaccharide-induced lung injury. Clin Sci (Lond) 2016;130:1993–2003. doi: 10.1042/CS20160360.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/CS20160360</ArticleId>
            <ArticleId IdType="pubmed">27549114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunne PD, Dasgupta S, Blayney JK, McArt DG, Redmond KL, Weir JA, Bradley CA, Sasazuki T, Shirasawa S, Wang T, et al.  EphA2 expression is a key driver of migration and invasion and a poor prognostic marker in colorectal cancer. Clin Cancer Res. 2015;22:230–242. doi: 10.1158/1078-0432.CCR-15-0603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-15-0603</ArticleId>
            <ArticleId IdType="pmc">PMC4694030</ArticleId>
            <ArticleId IdType="pubmed">26283684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whitman E, Barber A. NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells. Mol Immunol. 2015;63:268–278. doi: 10.1016/j.molimm.2014.07.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molimm.2014.07.015</ArticleId>
            <ArticleId IdType="pubmed">25089028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng CY, Huang WR, Chi PI, Chiu HC, Liu HJ. Cell entry of bovine ephemeral fever virus requires activation of Src-JNK-AP1 and PI3K-Akt-NF-κB pathways as well as Cox-2-mediated PGE2/EP receptor signalling to enhance clathrin-mediated virus endocytosis. Cell Microbiol. 2015;17:967–987. doi: 10.1111/cmi.12414.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cmi.12414</ArticleId>
            <ArticleId IdType="pubmed">25582828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daniel AR, Gaviglio AL, Knutson TP, Ostrander JH, D'Assoro AB, Ravindranathan P, Peng Y, Raj GV, Yee D, Lange CA. Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes. Oncogene. 2015;34:506–515. doi: 10.1038/onc.2013.579.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/onc.2013.579</ArticleId>
            <ArticleId IdType="pmc">PMC4112172</ArticleId>
            <ArticleId IdType="pubmed">24469035</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu Y, Zhang Y, Wang L, Diao Z, Liu W. The role of autophagy in kidney inflammatory injury via the NF-κB route induced by LPS. Int J Med Sci. 2015;12:655–667. doi: 10.7150/ijms.12460.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/ijms.12460</ArticleId>
            <ArticleId IdType="pmc">PMC4532974</ArticleId>
            <ArticleId IdType="pubmed">26283886</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang J, He Y, Mcleod HL, Xie Y, Xiao D, Hu H, Chen P, Shen L, Zeng S, Yin X, et al.  miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/β-catenin/EMT signaling cascade in gastric cancer. BMC Cancer. 2017;17:886. doi: 10.1186/s12885-017-3875-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12885-017-3875-3</ArticleId>
            <ArticleId IdType="pmc">PMC5741943</ArticleId>
            <ArticleId IdType="pubmed">29273006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma B, Hottiger MO. Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation. Front Immunol. 2016;7:378. doi: 10.3389/fimmu.2016.00378.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2016.00378</ArticleId>
            <ArticleId IdType="pmc">PMC5031610</ArticleId>
            <ArticleId IdType="pubmed">27713747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma B, Fey M, Hottiger MO. WNT/β-catenin signaling inhibits CBP-mediated RelA acetylation and expression of proinflammatory NF-κB target genes. J Cell Sci. 2015;128:2430–2436. doi: 10.1242/jcs.168542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.168542</ArticleId>
            <ArticleId IdType="pubmed">26021349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Voutilainen M, Lindfors PH, Trela E, Lönnblad D, Shirokova V, Elo T, Rysti E, Schmidt-Ullrich R, Schneider P, Mikkola ML. Ectodysplasin/NF-κB promotes mammary cell Fate via Wnt/β-catenin pathway. PLoS Genet. 2015;11:e1005676. doi: 10.1371/journal.pgen.1005676.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.1005676</ArticleId>
            <ArticleId IdType="pmc">PMC4651331</ArticleId>
            <ArticleId IdType="pubmed">26581094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huang H, Li R, Yuan J, Zhou X, Liu X, Ou S, Xu T, Chen Y. Up-regulated ephrinB3/EphB3 expression in intractable temporal lobe epilepsy patients and pilocarpine induced experimental epilepsy rat model. Brain Res. 2016;1639:1–12. doi: 10.1016/j.brainres.2016.02.035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainres.2016.02.035</ArticleId>
            <ArticleId IdType="pubmed">26930615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dong LD, Gao F, Wang XH, Miao Y, Wang SY, Wu Y, Li F, Wu J, Cheng XL, Sun XH, et al.  GluA2 trafficking is involved in apoptosis of retinal ganglion cells induced by activation of EphB/EphrinB reverse signaling in a rat chronic ocular hypertension model. J Neurosci. 2015;35:5409–5421. doi: 10.1523/JNEUROSCI.4376-14.2015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4376-14.2015</ArticleId>
            <ArticleId IdType="pmc">PMC6705403</ArticleId>
            <ArticleId IdType="pubmed">25834064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eusemann TN, Willmroth F, Fiebich B, Biber K, van Calker D. Adenosine receptors differentially regulate the expression of regulators of G-protein signalling (RGS) 2, 3 and 4 in astrocyte-like cells. PLoS One. 2015;10:e0134934. doi: 10.1371/journal.pone.0134934.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0134934</ArticleId>
            <ArticleId IdType="pmc">PMC4532427</ArticleId>
            <ArticleId IdType="pubmed">26263491</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
